2
Clinical Trials associated with JWK008A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of JWK008 Given by a Single Intravenous Infusion in Patients With Mucopolysaccharidosis Type I
This study is a single-center, single-arm, non-randomized, open-label, non controlled, dose-escalation, prospective clinical trial designed to assess the safety, tolerability, and preliminary efficacy of JWK008 injection in patients with MPS I.
A clinical study evaluating the safety, tolerability, and initial efficacy of JWK008 given by a single intravenous infusion in patients with MPS I
Start Date15 Jan 2024 |
Sponsor / Collaborator- |
100 Clinical Results associated with JWK008
100 Translational Medicine associated with JWK008
100 Patents (Medical) associated with JWK008
100 Deals associated with JWK008